Arthrogryposis: all 85 studies

Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Impact Study on Users of Upper Limb Assistive DevicesRecruitingNCT07429188
• Piezo2-related Arthrogryposis & physiopathOLOgy 3Not yet recruitingNCT07360574
• Analysis of Patients With Autosomal Dominant Polycystic KidneyRecruitingNCT06759142
• Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease TreatmentRecruitingNCT06618638Not applicable
• Continuous Passive Motion Device for Children With ArthrogryposisNot yet recruitingNCT06192134Not applicable
• Technical Feasibility Study of Ultrasound Muscle Imaging in Antenatal UltrasoundRecruitingNCT06130592Not applicable
• National Registry of Rare Kidney DiseasesRecruitingNCT06065852
• Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney DiseaseEnrolling by invitationNCT05870007Phase 2
• Ready, Set, Go! A Physical Fitness Intervention for Children With Mobility ChallengesEnrolling by invitationNCT04789746Not applicable
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
• Effect of Beetroot Juice on Reducing Hypertension in Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT05401409Not applicableResults posted
• Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1CompletedNCT04581629Phase 2Results posted
• A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)TerminatedNCT04578548Phase 2Results posted
• Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney DiseaseTerminatedNCT04064346Phase 3Results posted
• A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCONTerminatedNCT03918447Phase 3Results posted
• The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT03487913Phase 2Results posted
• Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT03342742Not applicableResults posted
• Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKDCompletedNCT03203642Phase 2Results posted
• Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)CompletedNCT02964273Phase 3Results posted
• Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02656017Phase 2Results posted
• Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02251275Phase 3Results posted
• WREX Outcome StudyCompletedNCT02218593Results posted
• A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium ConcentrationsCompletedNCT02204579Phase 2Results posted
• Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02160145Phase 3Results posted
• Pasireotide LAR in Severe Polycystic Liver DiseaseCompletedNCT01670110Phase 2Results posted
• A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT01559363Phase 1/2Results posted
• 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT01451827Phase 2Results posted
• Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT01336972Phase 2Results posted
• A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]CompletedNCT01280721Phase 3Results posted
• Bosutinib For Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT01233869Phase 2Results posted
• Tolvaptan Extension Study in Participants With ADPKDCompletedNCT01214421Phase 3Results posted
• A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]CompletedNCT01022424Phase 3Results posted
• Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to TherapyTerminatedNCT00920309Phase 2/3Results posted
• A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]CompletedNCT00841568Phase 2Results posted
• Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00456365Phase 3Results posted
• Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00428948Phase 3Results posted
• Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT00414440Phase 4Results posted
• Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00413777Phase 2Results posted
• Study of Tamibarotene in Patients With ADPKDActive, not recruitingNCT06289998Phase 2
• Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 MutationTerminatedNCT06140329
• Pediatric and Adult Registry for Patients With ARThrogryposisStatus unknownNCT05673265
• A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT05521191Phase 1
• Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic CystsStatus unknownNCT05500157Not applicable
• Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon SyndromeStatus unknownNCT05419245
• Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional EvaluationCompletedNCT05393375
• Mercuri Analysis Contribution on Handicap Evaluation in ArthrogypOsis, a Congenital Neuromuscular DiseaseCompletedNCT05137756
• NuroSleeve Powered Brace & Stimulation System to Restore Arm FunctionActive, not recruitingNCT04798378Not applicable
• Genetic Testing and Motivational Counseling for FHActive, not recruitingNCT04656028Not applicable
• A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04536688Phase 1
• Time Restricted Feeding in Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04534985Not applicable
• The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04363554Not applicable
• Wishing to Decrease Aquaresis in ADPKD Patients Treated With a V2Ra; the Effect of Regulating Protein and SaltStatus unknownNCT04310319Not applicable
• A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO GeneActive, not recruitingNCT04123626Phase 1/2
• Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney DiseaseCompletedNCT03949894Phase 4
• Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney DiseaseStatus unknownNCT03596957Phase 4
• A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT03102632Not applicable
• Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical TrialCompletedNCT02948179Not applicable
• The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating PainWithdrawnNCT02746419Not applicable
• Characterization of Patients With Non-surgical Hypoparathyroidism and PseudohypoparathyroidismStatus unknownNCT02551120
• Clinical Implications of DNA Analysis on ADPKDCompletedNCT02322385
• New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02250287
• Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.CompletedNCT02233322Not applicable
• The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted RecipientsCompletedNCT02134899Phase 3
• Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)Status unknownNCT02115659Phase 3
• Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKDCompletedNCT02112136Not applicable
• Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney DiseaseStatus unknownNCT02055079Phase 3
• Repository Study of Autosomal Dominant Polycystic Kidney DiseaseWithdrawnNCT01988038
• Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression ControlStatus unknownNCT01932450Phase 2
• A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)CompletedNCT01810614Not applicable
• Advanced Characterization of Autosomal Dominant Optic AtrophyStatus unknownNCT01522638
• Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal InsufficiencyCompletedNCT01377246Phase 3
• Efficacy Study of Water Drinking on PKD Progression.CompletedNCT01348035
• Study of Quality of Life in Freeman-Sheldon Syndrome and Related ConditionsTerminatedNCT01307475
• Study of Resting and Exercising Body Functioning in Freeman-Sheldon Syndrome and Related ConditionsWithdrawnNCT01306994
• Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / GenesCompletedNCT01235624Not applicable
• Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal InsufficiencyTerminatedNCT01223755Phase 2/3
• Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon SyndromeTerminatedNCT01144741
• Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT01114594
• Effects of Power Mobility on Young Children With Severe Motor ImpairmentsCompletedNCT01028833Phase 2
• Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)Status unknownNCT00890279Phase 2
• Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00759369Not applicable
• Adrenal Functions in Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT00598377Not applicable
• Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain StudyCompletedNCT00571909Not applicable
• The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT00410007Not applicable
• Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00346918Phase 3

← Arthrogryposis overview